Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123180) titled 'A multicenter, randomized, non-inferiority clinical study of corticosteroids combined with adalimumab biosimilar versus corticosteroids combined with immunosuppressants for the treatment of non-infectious uveitis' on April 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shenzhen Eye Hospital

Condition: Non-infectious uveitis

Intervention: Test group:Corticosteroids + Adalimumab

Recruitment Status: Recruiting

Phase: 4

Date of First Enrollment: 2024-07-12

Target Sample Size: Test group:60;Control group:60;

Countries of Recruitment: China

To know more, visit https://www.ch...